ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
|---|---|---|---|---|
| Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS | St. Jude Children’s Research Hospital / Dirk Loeffler, PhD | RUNX1 Early Career Investigator Grants | 2023 | Tennessee |
| GENOME ORIGAMI: Refolding Aberrant Chromosome 3D Structure for Treating NUT Carcinoma | Baylor College of Medicine / Kyle Eagen, PhD | R Accelerated Award Grants | 2022 | Texas |
| Phase I trial of multilamellar mRNA lipid particles for recurrent pediatric high grade glioma | University of Florida / Elias Sayour, MD/PhD | R Accelerated Award Grants | 2022 | Florida |
| Characterizing the Developmental Context of Pediatric Leukemia | Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD | 'A' Award Grants | 2022 | New York |
| Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL | Temple University / Christian Hurtz, PhD | 'A' Award Grants | 2022 | Pennsylvania |
| Epigenetic therapies to concurrently target DIPG tumor cells and harness the immune system | The Regents of the University of Michigan / Sriram Venneti, MD/PhD | R Accelerated Award Grants | 2022 | Michigan |
| Exploiting glypican diversity in neuroblastoma plasticity with bicistronic CAR T cell targeting | Children’s Hospital of Philadelphia / Kristopher Bosse, MD | 'A' Award Grants | 2022 | Pennsylvania |
| Novel Therapy for Pediatric Leukemia Patients with NUP98 Translocations | The Regents of the University of Michigan / Jolanta Grembecka, PhD | Reach Grants | 2022 | Michigan |
| Mechanistic and Therapeutic Development of ATM as a Tumor Cell Selective Target for Radiosensitization in H3K27M DMG | The Regents of the University of Michigan / Meredith Morgan, PhD & Daniel Wahl, MD/PhD | Reach Grants | 2022 | Michigan |
| Enhancing TKI Therapy in Ph-Like Leukemia | The Regents of the University of California, Irvine / David Fruman, PhD | Reach Grants | 2022 | California |